-+ 0.00%
-+ 0.00%
-+ 0.00%

TRANSCENTA THERAPEUTICS AND WUXI BIOLOGICS ENTER INTO STRATEGIC COLLABORATION TO ACCELERATE COMMERCIALIZATION OF HICB CONTINUOUS BIOPROCESSING TECHNOLOGIES

Reuters·09/09/2026 12:00:10

Please log in to view news